KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) FCF Payout Ratio (2016 - 2025)

West Pharmaceutical Services' FCF Payout Ratio history spans 17 years, with the latest figure at 0.09 for Q4 2025.

  • For Q4 2025, FCF Payout Ratio rose 141.47% year-over-year to 0.09; the TTM value through Dec 2025 reached 0.13, up 32.59%, while the annual FY2025 figure was 0.13, 32.59% up from the prior year.
  • FCF Payout Ratio for Q4 2025 was 0.09 at West Pharmaceutical Services, down from 0.11 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 0.53 in Q1 2024 and bottomed at 0.29 in Q3 2024.
  • The 5-year median for FCF Payout Ratio is 0.12 (2022), against an average of 0.14.
  • The largest annual shift saw FCF Payout Ratio surged 193.13% in 2021 before it plummeted 375.98% in 2024.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.16 in 2021, then crashed by 76.92% to 0.04 in 2022, then decreased by 7.42% to 0.03 in 2023, then grew by 10.93% to 0.04 in 2024, then surged by 141.47% to 0.09 in 2025.
  • Per Business Quant, the three most recent readings for WST's FCF Payout Ratio are 0.09 (Q4 2025), 0.11 (Q3 2025), and 0.15 (Q2 2025).